Market closed
Cerus/$CERS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cerus
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Ticker
$CERS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
622
Website
Cerus Metrics
BasicAdvanced
$242M
-
-$0.11
1.29
-
Price and volume
Market cap
$242M
Beta
1.29
52-week high
$2.54
52-week low
$1.12
Average daily volume
1.5M
Financial strength
Current ratio
2.39
Quick ratio
1.733
Long term debt to equity
134.5
Total debt to equity
172.415
Interest coverage (TTM)
-1.60%
Management effectiveness
Return on assets (TTM)
-4.46%
Return on equity (TTM)
-37.99%
Valuation
Price to revenue (TTM)
1.331
Price to book
4.3
Price to tangible book (TTM)
4.4
Price to free cash flow (TTM)
28.155
Growth
Revenue change (TTM)
15.29%
Earnings per share change (TTM)
-46.03%
3-year revenue growth (CAGR)
11.27%
3-year earnings per share growth (CAGR)
-29.25%
What the Analysts think about Cerus
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Cerus stock.
Cerus Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Cerus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Cerus News
AllArticlesVideos
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
Business Wire·4 days ago
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
Business Wire·2 months ago
Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cerus stock?
Cerus (CERS) has a market cap of $242M as of April 21, 2025.
What is the P/E ratio for Cerus stock?
The price to earnings (P/E) ratio for Cerus (CERS) stock is 0 as of April 21, 2025.
Does Cerus stock pay dividends?
No, Cerus (CERS) stock does not pay dividends to its shareholders as of April 21, 2025.
When is the next Cerus dividend payment date?
Cerus (CERS) stock does not pay dividends to its shareholders.
What is the beta indicator for Cerus?
Cerus (CERS) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.